Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Artificial Fertility Specialist Secures £65,000 Investment

Published: Friday, May 03, 2013
Last Updated: Friday, May 03, 2013
Bookmark and Share
Funding received from The North West Fund for Biomedical.

An emerging artificial fertility specialist company, whose work could reduce the number of animals used in research by 24 per cent, has secured £65,000 investment from The North West Fund for Biomedical, managed by SPARK Impact.

Studies have shown Ostara’s technology to be effective in substantially enhancing livestock breeding programmes and ultimately improving the efficiency of current breeding techniques.   

In addition to domestic species, it could also be used to increase the reproductive success of rare animals and endangered species. In the longer term, Ostara’s technology could be deployed to boost success rates of existing human infertility treatment practices.

Investing the money is The North West Fund for Biomedical which is part of the wider £155m North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank.

Dr Nadia Gopichandran, co-founder and chief technical director of Ostara, said: “We are very excited to receive this funding. I would like to thank SPARK Impact and The North West Fund for Biomedical for investing in Ostara, and giving us the opportunity to develop new products in the fertility field.

“The investment means we can push on with our plans to progress our technology further with the aim of launching a product in 2015.”

Dr Penny Attridge, senior investment director at SPARK Impact and fund manager for The North West Fund for Biomedical said: “The team at Ostara is passionate about this technology and we hope to see them succeed in taking this innovative product to market.”

Ostara Biomedical Ltd is The North West Fund for Biomedical’s 51st investment to date and 36th company to be supported by The Fund.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

North West Digital Clinical Trial Recruitment Company Secures Six Figure Investment
UK Company has secured an investment of more than £250,000.
Monday, July 22, 2013
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!